4,089 Shares in Cabot Co. (NYSE:CBT) Bought by Farringdon Capital Ltd.

Farringdon Capital Ltd. purchased a new stake in Cabot Co. (NYSE:CBT) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 4,089 shares of the specialty chemicals company’s stock, valued at approximately $373,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. R Squared Ltd acquired a new stake in Cabot in the fourth quarter valued at approximately $26,000. EverSource Wealth Advisors LLC raised its holdings in shares of Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock valued at $74,000 after purchasing an additional 219 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock worth $123,000 after purchasing an additional 130 shares during the last quarter. Manchester Capital Management LLC increased its holdings in Cabot by 1,685.1% in the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock valued at $153,000 after buying an additional 1,584 shares during the last quarter. Finally, KBC Group NV raised its stake in Cabot by 43.1% in the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock valued at $187,000 after buying an additional 616 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Price Performance

Shares of NYSE CBT opened at $78.40 on Friday. The stock has a market cap of $4.25 billion, a P/E ratio of 10.41, a P/E/G ratio of 0.74 and a beta of 1.04. Cabot Co. has a twelve month low of $73.63 and a twelve month high of $117.46. The stock has a 50 day moving average of $82.71 and a two-hundred day moving average of $94.90. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. On average, research analysts forecast that Cabot Co. will post 7.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Mizuho lowered their price objective on Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research report on Tuesday, January 7th. JPMorgan Chase & Co. dropped their price target on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. StockNews.com upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, UBS Group cut their price target on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research note on Monday, April 7th.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.